How do you pay?

How to pay the least

Ask for the cash price

Alunbrig

We didn’t find one.

  1. Ask your pharmacy for Alunbrig’s cash price, and one or two other pharmacies too.
  2. Alunbrig’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Takeda Oncology Patient Assistance Program (Takeda Oncology Here2Assist). To be eligible for the Patient Assistance Program, patients must meet certain financial and insurance coverage criteria. Or call 1-844-817-6468 (Option 2).

See if you qualify 

Compare every option

Question
Brand nameAlunbrig
Authorized genericbrigatinib
Regular genericbrigatinib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Alunbrig?
The original
–
–

Brand nameThe maker’s card

Takeda Oncology Co-Pay Assistance Program (Here2Assist)

Savings card from Takeda

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on alunbrig.com 

Or call 1-844-817-6468.

In the maker’s words

“Through this program, you may pay as little as $0 per prescription.”

From the maker’s offer on alunbrig.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Alunbrig itself, from the same company, sold without the brand name, and usually for less. For now Alunbrig is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ALUNBRIG is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

Source: the FDA label for Alunbrig (Takeda Pharmaceuticals America, Inc.), January 12, 2026. Full label on DailyMed 

Good to know